Delivery Order SPE2DB22D2206-SPE2DB24FHZ43

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Carvedilol ER 40 mg capsules to the Defense Logistics Agency (DLA). The contract, worth $1,098.58, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of Carvedilol ER 10 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
This federal contract award is for the delivery of Carvedilol ER 40 mg capsules in quantities of 30s, with a total ceiling value of $3,597. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 11, 2023. The award is not associated with any set-aside designation,...
This federal contract award is for the delivery of Carvedilol ER 20 mg capsules to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 1, 2024 with a ceiling value of $1,124.11. It is a firm-fixed-price delivery order contract with a completion date of May 2, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This federal contract award is for the delivery of Carvedilol ER 80 mg capsules to the Defense Logistics Agency (DLA). The $1,432.79 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 6, 2024. The contract has an ultimate completion date of November 7, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of Carvedilol ER 20 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract, valued at $10,238.23, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, which is a major pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order, with a completion date of March 25, 2024. Amerisourcebergen Drug...
This federal contract award is for the delivery of Carvedilol ER 10 mg capsules to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $1,133.02, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract is a delivery order issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Carvedilol ER 40 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price type, valued at $4,227.55, with an ultimate completion date of January 16, 2024. The contract was awarded on January 12, 2024, and there was no set-aside designation used. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of Carvedilol ER 80 mg capsules, placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $20,923.46 firm-fixed-price contract has an ultimate completion date of April 21, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award is for the delivery of Carvedilol ER 40 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $16,899.29, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a completion date of December 8, 2023. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FHZ43
    Delivery Order

This federal contract award is for the delivery of Carvedilol ER 40 mg capsules to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for a ceiling value of $14,732.77. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 1, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award is not associated with any set-aside designation.

Generated 9/27/24, 9:27 AM